Inicio › Cáncer de seno › California › Newport Beach
Ensayos clínicos de Cáncer de seno en Newport Beach, CA
16 estudios para Cáncer de seno buscan participantes en centros de Newport Beach y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
ReclutandoFase 1
- Research Site, Newport Beach
IKS014 in Advanced Solid Tumors That Express HER2
ReclutandoFase 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
ReclutandoFase 3
- Hoag Memorial Hospital Presbyterian ( Site 0025), Newport Beach
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
ReclutandoFase 3
- Hoag Memorial Hospital Presbyterian ( Site 0010), Newport Beach
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
ReclutandoFase 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
ReclutandoFase 3
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
ReclutandoFase 1/2
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
ReclutandoFase 3
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
ReclutandoFase 1
- Hoag Family Cancer Institute, Newport Beach
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
ReclutandoFase 2/3
- USC Norris Oncology/Hematology-Newport Beach, Newport Beach
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
ReclutandoFase 1
- USC Norris Oncology/Hematology-Newport Beach, Newport Beach
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- Hoag Memorial Hospital Presbyterian, Newport Beach
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
ReclutandoFase 2
- HOAG Memorial Hospital Presbyterian, Newport Beach
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
ReclutandoEstudio observacional
- USC Norris Oncology/Hematology-Newport Beach, Newport Beach
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
ReclutandoFase 3
- City of Hope Newport Beach, Newport Beach
Perioperative Mindfulness Proposal
Reclutando
- Hoag Memorial Hospital Presbyterian, Newport Beach
Más información sobre Cáncer de seno en MedlinePlus
Ensayos de Cáncer de seno en otras ciudades
- New York City, NY136 estudios
- Houston, TX126 estudios
- Boston, MA112 estudios
- Nashville, TN81 estudios
- Los Angeles, CA73 estudios
- Edison, NJ68 estudios
- St. Louis, MO64 estudios
- Queens, NY64 estudios
- Durham, NC64 estudios
- Chicago, IL59 estudios
- Philadelphia, PA56 estudios
- Dallas, TX55 estudios
Otros estudios en Newport Beach
- Cáncer de pulmón de células no pequeñas14 estudios
- Cáncer metastásico10 estudios
- Enfermedad de obstrucción pulmonar crónica9 estudios
- Cáncer de ovario9 estudios
- Cáncer de endometrio7 estudios
- Cáncer de pulmón7 estudios
- Cáncer del colon y del recto6 estudios
- Cáncer de próstata6 estudios
- Cáncer de mama triple negativo6 estudios
- Cáncer (todos los tipos)6 estudios
- Carcinoma de células escamosas de cabeza y cuello5 estudios
- Cáncer de riñón (carcinoma de células renales)5 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.